Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

2.11
Delayed Data
As of Feb 27
 +0.06 / +2.93%
Today’s Change
1.25
Today|||52-Week Range
5.73
+41.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Operating ActivitiesNet Income / Starting Line-5.7M-10.7M-6.0M-13.3M
 
 
 
 
 
Depreciation812.0K831.0K839.0K846.0K
 
 
 
 
 
Total Other Cash Flow-4.4M2.4M-6.4M2.6M
 
 
 
 
 
Funds From Operations-9.3M-7.5M-11.5M-9.9M
 
 
 
 
 
Funds From/For Other Operating Expenses1.3M3.6M1.9M-103.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-10.7M-11.2M-13.5M-9.8M
 
 
 
 
 
 
InvestingIncrease In Investments-8.6M0.00-33.1M-1.0K
 
 
 
 
Decrease In Investments8.7M8.6M0.009.8M
 
 
 
 
Capital Expenditures-296.0K-174.0K-2.3M-81.0K
 
 
 
 
 
Net Cash Flow Investing-231.0K8.4M-35.4M9.7M
 
 
 
 
 
 
FinancingShort Term Borrowings-5.0M0.000.000.00
 
 
Long Term Borrowings15.0M45.8M5.0M0.00
 
 
 
 
Long Term Debt Reduction-5.8M-189.0K-194.0K-201.0K
 
 
 
 
 
Net Proceeds Stock Sale137.0K11.0K187.0K16.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.007.1M-1.3M-1.4M
 
 
 
 
Net Cash Flow - Financing4.4M38.5M6.3M1.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash-6.5M35.8M-42.6M1.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account